Pyrazolo [1, 5 -alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists

Details for Australian Patent Application No. 2006298995 (hide)

Owner Neurocrine Biosciences Inc SmithKline Beecham (Cork) Limited

Inventors Hossner, Frank

Agent Davies Collison Cave

Pub. Number AU-B-2006298995

PCT Pub. Number WO2007/039264

Priority PCT/ US2005/037576 19.10.05 US; 0519957.5 30.09.05 GB

Filing date 28 September 2006

Wipo publication date 12 April 2007

Acceptance publication date 14 June 2012

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/039264 Priority application(s): WO2007/039264

30 October 2008 Assignment before Grant

  SB Pharmco Puerto Rico Inc; Neurocrine Biosciences Inc The application has been assigned to Neurocrine Biosciences Inc; SmithKline Beecham (Cork) Limited

14 June 2012 Application Accepted

  Published as AU-B-2006298995

11 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006299016-Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2

2006298964-Plants having an increased content of amino sugars